Core Laboratories Inc. (CLB) vs Kinetik Holdings Inc. (KNTK)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| CLB | KNTK | |
|---|---|---|
| Sector | Energy | Energy |
| Industry | Oil & Gas Equipment & Services | Oil & Gas Midstream |
| Size band | SMALL | MID |
| Listing | NYSE | NYSE |
| Country | United States | United States |
| Theme | oil-and-gas-services | oil-and-gas-midstream |
| Price and returns | ||
| Last close | $10.22 | $55.97 |
| Return · 1 week | +0.69% | +3.96% |
| Return · 1 month | +1.89% | +9.30% |
| Return · 3 months | −4.40% | +13.32% |
| Return · year to date | −39.63% | +59.30% |
| Return · 1 year | −39.27% | +47.98% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −49.80% | −1.67% |
| 52-week high | $20.36 | $56.92 |
| 52-week low | $9.13 | $31.33 |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $468.94M | $9.47B |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $5.96M | $62.28M |
| Employees | 3,300 | 500 |
| Valuation | ||
| Price to earnings · trailing | 19.06× | 19.48× |
| Price to earnings · forward | 14.36× | 21.34× |
| Price to sales | 0.88× | 5.00× |
| Price to book | 1.67× | n/a (negative book value) |
| Enterprise value to EBITDA | 10.56× | 20.02× |
| Enterprise value to revenue | 1.16× | 6.65× |
| PEG ratio | 1.44 | 3.49 |
| Earnings per share · trailing | 0.52 | 2.86 |
| Profitability | ||
| Gross margin | 16.66% | 34.59% |
| Operating margin | 7.36% | 23.04% |
| Profit margin | 4.69% | 9.83% |
| Return on equity | 9.05% | 19.23% |
| Return on assets | 4.45% | 1.96% |
| Growth | ||
| Revenue growth | −4.30% | +36.30% |
| Earnings growth | −41.20% | +95.20% |
| Balance sheet and payout | ||
| Debt / equity (%) | 59.23 | 136.57 |
| Current ratio | 2.12 | 0.68 |
| Dividend yield | 0.40% | 5.82% |
| Payout ratio | 7.69% | 111.19% |
| Trend and volatility | ||
| RSI · 14 | 48.10 | 59.04 |
| ADX · 14 | 32.00 | 12.45 |
| 50-day average | $11.15 | $53.93 |
| 200-day average | $14.04 | $48.36 |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 3.81% | 2.80% |
The full CLB analysis
Everything this table leaves out for Core Laboratories Inc.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the CLB argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full CLB analysisThe full KNTK analysis
Everything this table leaves out for Kinetik Holdings Inc.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the KNTK argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full KNTK analysis